Interest of iRECIST Evaluation for DCR for Evaluation of Patients With Deficient MMR and /or MSI Metastatic Colorectal Cancer Treated With Nivolumab and IpilimumabIn Vivo Assessment of the Elastic Properties of Women's Pelvic Floor During PregnancyGemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryRadiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerProspective Multicentric Evaluation of a Bladder Preservation StrategyRadiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal CancerChronic Pulmonary Aspergillosis and Ambisome Aerosol With ItraconazoleStudy on the Occurrence of Head and Neck Cancers During PregnancyStudy of Ponatinib (Iclusig) for Prevention of Relapse After Allogeneic Stem Cell Transplantation (Allo-SCT) in FLT3-ITD AML PatientsOCT Angiography in Arteritic and Non Arteritic Anterior Ischemic NeuropathyTriptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerWhole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast CancerDexmedetomidine After Cardiac Surgery for Prevention of DeliriumA Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal CarcinomaMedico-economic Evaluation of Subcutaneous Automatic Resorbable Staples DeviceEvaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and NeckVASO-AM :Impact of Oral Appliance Therapy on Endothelial Function in Obstructive Sleep ApneaTreatment of Mycobacterium Xenopi Pulmonary InfectionDisease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)Multi-Omics and IPSCs to Improve Diagnosis of Rare Intellectual DisabilitiesEarly Initiation of High-flow Nasal Cannula Oxygen Therapy in Patients With Acute Respiratory Failure in the Emergency Department: A Before-after StudyThe Artificial Kidney Initiation in Kidney Injury 2A Study to Investigate a New Treatment in Patients With Parkinson's DiseaseLiving After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of ChemotherapyEnd Of Life in the Critically Ill patiEntPsoriatic Inflammation Markers Predictive of Response to AdalimumabPrevalence Study : Elderly Patients and Rehabilitation in ICU. Impact of Frailty.Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown AetiologyA Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's DiseasePrevalence of Pressure Ulcers Among Critically Ill Patients and Factors Associated With Their Occurrence in the ICURituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaIpatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
P6153
Q39381962-84D23D08-F73A-432B-82B3-DE44327A455CQ59694261-A64B8D46-09F5-4E44-AD8A-9263DB3EAB72Q60042373-3387A1B6-9E69-4E6A-A1EF-9DDC2C620F61Q64225808-5D8E40AC-4EB8-4701-9F8D-F7BCC9B787EDQ82667730-040EB588-143F-4074-9063-CA5638F315DEQ82734203-F67FBA0F-8A2E-42CD-AD01-1A9340682C72Q86595295-0260386E-B053-4B9F-8B49-8DA4A18C95E1Q86748088-1F5085FD-EED0-4C04-85C9-258E6CFFA656Q87919361-C110D40A-CE1F-4144-AFA6-6762797E2447Q88167428-7D77E4B5-40B3-4AA8-94F6-6022DC7E3CF8Q89400272-53A99525-98BA-4C41-8B1E-DBB25B3096E2Q90019656-81D5E7D5-C0F0-4488-BEBA-09B08AF1ECB2Q90070464-26C43ECC-C93C-4E45-B682-EFA4AC25EC52
P108
Q58407631-2B3F7C4F-C0E9-4819-8E26-80E05CA13BEFQ61907572-414DD535-AECB-46E6-BCE7-5028D25E43CDQ61915483-AF4A9C7D-A195-4C8B-A448-D1A20E3D2DDBQ61921688-49CA35FC-9100-4D29-BA48-308B631C0662Q61936921-B9C46BFC-96B4-4CDB-B014-8CC5509077C0Q61981439-D9707144-19EA-461E-8DE7-4BE92B7E79A4Q62024923-8EF0063E-E408-4B9B-BC30-1345847BFF97Q62035330-17484EAE-66EA-4E57-9562-BD3971AFBFEAQ62054192-51463F1B-0177-4BD6-ADE0-2BE3CE2D8284Q62062749-77FBB2D7-A473-4E05-BF61-2EFC814D2FA7Q62105842-1DE0052B-A136-4D99-B879-48FD3B80F085Q62111080-387F5924-19AD-4715-BCB2-3C918065BC55Q62813055-F028268D-9093-475E-A7A3-16AD4E898205Q62816966-EB06E923-1CA1-4C85-8968-0B805D6E1E83Q63317045-B369954A-662C-4ADF-8494-B1CFB99C4203Q63320880-CCAA316C-15C1-4172-955F-78397F22F2DAQ63321086-5255BEC2-DBC7-4BBC-BCDE-42B7C6C6C65FQ63338705-24F101ED-B5E0-44EB-B1C9-9A152F8D04B8Q63393762-AD0D84CD-E6BF-4074-944B-FC84118873EFQ63394258-218F982F-9E80-486A-A4AF-79BD7A5E2F6BQ63401492-DAD50D7D-9633-4EBB-8A14-B83407601809Q63403433-B283A447-0299-4D60-92FA-3A7F64217D1CQ63403929-78B4CCB6-1895-48AD-A510-D06A7D6ADCCEQ63404086-130DB216-DEAD-4646-A542-DF259585A9DAQ63404617-79D71458-2E77-4A2E-8639-4E21B685FCCCQ63405324-EC44D026-6260-4C62-9867-E6254DAA6BA8Q63534259-CD008920-CBF8-4928-8965-B6BBC8E46AB0Q63573210-2A2B270C-E66A-4089-B61B-DC1D513D4B3BQ63573532-D0135BA2-EEA7-415A-B1BD-D11EC4A071E2Q63578961-D7054902-1930-42FA-8930-DA2B9C5A2471Q64171007-E2CF6E26-03AB-47D6-8BC5-0CF71AD9A954Q64172768-90E06BDC-9F60-41FF-BF76-6F83AF335439
P6153
name
CHU Poitiers
@en
centre hospitalier universitaire de Poitiers
@fr
普瓦捷大学附属中心医院
@zh
普瓦捷大学附属中心医院
@zh-hans
普瓦捷大學附屬中心醫院
@zh-hant
type
label
CHU Poitiers
@en
centre hospitalier universitaire de Poitiers
@fr
普瓦捷大学附属中心医院
@zh
普瓦捷大学附属中心医院
@zh-hans
普瓦捷大學附屬中心醫院
@zh-hant
prefLabel
CHU Poitiers
@en
centre hospitalier universitaire de Poitiers
@fr
普瓦捷大学附属中心医院
@zh
普瓦捷大学附属中心医院
@zh-hans
普瓦捷大學附屬中心醫院
@zh-hant
P214
P244
P131
P1616
P17
P213
0000 0000 9336 4276
P214
P2427
grid.411162.1
P244
P3500
P3608
FR1A268600012
P4058
P571
1950-01-01T00:00:00Z
P5785
P625
Point (0.385 46.559)
P6413
P6782
P7859
lccn-n00121933